Please be aware that all information shared here at Canada Pharmacy has been medically reviewed and fact-checked for accuracy. These verifications are made by board-certified medical professionals who have the authority required to state that information related to medical conditions, symptoms, procedures and tests, and standard treatment protocols is valid and truthful. This is based on current guidelines and consensuses shared amongst medical professionals, and in representation of the latest research.
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Also Known as Lixiana
Sign up to get exclusive coupon discounts and be the first to be notified when we have this product available.
Savaysa is a prescription medication used to prevent strokes that could result from atrial fibrillation. It is also a DVT medication for treating deep vein thrombosis to prevent blood clots in the leg or can also be used to treat a pulmonary embolism in the lungs. For DVT or embolism Savaysa will usually be used with a blood thinner prior to beginning on the medication. This medication for atrial fibrillation without heart valve problem is known to be very effective for stroke prevention, and you can buy Savaysa drug with a prescription at most pharmacies and maybe find a better Savaysa cost ordering medication online.
For atrial fibrillation treatment, take one 60 mg tablet orally one time each day.
For DVT treatment and pulmonary embolism, take one 60 mg Savaysa orally one time each day after 5 to 10 days of initial therapy with a parenteral anticoagulant (blood thinner).
Your doctor may reduce your Savaysa medication dosage if you have a lower than average body weight for your size.
The active ingredient in Savaysa is Edoxaban.
Your doctor should examine you for health kidney function before beginning on Savaysa medication. Individuals with renal failure or a history of kidney disease may not be suitable for a Savaysa prescription.
Be aware that Savaysa can cause you to bruise and bleed more easily. If you are prone to this, you should discuss with your doctor before moving forward with the medication.
Savaysa will not be suitable for people with mechanical heart valves or those who have moderate-to-severe narrowing (stenosis) of their mitral valve. This medication is also not suitable for anyone with antiphospholipid syndrome (APS) who have a history of blood clots.
Do not take Savaysa is you are pregnant or plan to become pregnant unless advised by your doctor to do so.
There is the possibility of drug interactions between Savaysa and aspirin, nonsteroidal anti-inflammatory drugs (NSAIDs), blood thinners like Warfarin, Heparin, or other medicines to prevent or treat blood clots, selective serotonin reuptake inhibitors (SSRIs), and serotonin norepinephrine reuptake inhibitors (SNRIs) which are common among antidepressant and mood regulation medications.
It is always best to tell your doctor of all medications you are currently taking when you meet to speak about blood clot and stroke prevention medication.
Side effects from Savaysa are rare, but some people may experience burning sensation, skin redness or swelling, itching or rash.
In the event of severe side effects or ones that worsen you should discontinue use and speak with your doctor again to look at stroke from atrial fibrillation prevention options.